536565 — Novelix Pharmaceuticals Balance Sheet
0.000.00%
- IN₹264.77m
- IN₹263.25m
- IN₹42.24m
- 15
- 12
- 94
- 33
Annual balance sheet for Novelix Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | R2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 11.2 | 20.8 | 26 | 27.7 | 1.18 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 79.6 | 37.5 | 11.9 | 2.68 | 0.134 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 114 | 73.3 | 46.3 | 42.4 | 41.3 |
Net Property, Plant And Equipment | 17.8 | 16.2 | 2.26 | 1.74 | 1.18 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 137 | 95.7 | 72.5 | 72.6 | 73.6 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 18.1 | 21.7 | 0.082 | 0.616 | 0.101 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 31.2 | 27.1 | 0.082 | 0.616 | 0.101 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 106 | 68.6 | 72.4 | 72 | 73.5 |
Total Liabilities & Shareholders' Equity | 137 | 95.7 | 72.5 | 72.6 | 73.6 |
Total Common Shares Outstanding |